Syncope Clinical Trial
Official title:
Validation of the Canadian Prehospital Syncope Risk Score
Background: Syncope is defined as a sudden, brief loss of consciousness (LOC) followed by a rapid complete recovery. It accounts for 160,000 emergency department (ED) visits each year in Canada. Despite this, few people are hospitalized (~15%) and even fewer will die (~1%). Two-thirds of patients with syncope arrive at the ED by calling 911. There are many causes of syncope. Identifying patients at low risk for bad outcomes would allow paramedics to safely determine which patients need care in the ED from those who can remain home. The research team recently developed the Canadian Prehospital Syncope Risk Score (CPSRS) which accurately identified patients at low risk for 30-day serious outcomes. Objective: The goal of this study is to validate the accuracy of the CPSRS in the prehospital setting or refine if needed to predict the risk of 30-day serious outcomes for patients with syncope. Methods: The research team will enroll patients with syncope from five paramedic services across Canada (British Columbia - Vancouver and Kelowna areas only, London-Middlesex, York Region, Frontenac, and Ottawa). The research team will exclude patients <18 years old, LOC >5 minutes, changes in mental status from baseline, alcohol or drug intoxication, or language barrier. Paramedics will fill out a study data collection form with the CPSRS items and additional data should the tool need refinement. The data will be entered into a secure database and will assess patient outcomes (death and potentially life-threatening medical conditions) at 30 days. The research team will examine model accuracy using standard prediction measures and look to improve model accuracy if needed. The research team expects to enroll 4875 patients over a 1-year recruitment period based on annual call volumes. Expected Outcomes: Once validated, the tool could reduce the number of patients transported to the hospital by identifying those at low risk. This would improve patient-oriented care, while at the same time saving valuable paramedic and ED resources.
Status | Not yet recruiting |
Enrollment | 4875 |
Est. completion date | March 31, 2025 |
Est. primary completion date | March 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients who access paramedic services through the 911 system will be included if they have suffered syncope, defined as a sudden transient loss of consciousness followed by spontaneous complete recovery. Exclusion Criteria: - Pediatric patients (<18 years old), - Patients who have a prolonged period of unconsciousness (>5 minutes), - Change in mental status from baseline, witnessed seizure, - Loss of consciousness due to head trauma (i.e., trauma was the initial event), - or if unable to provide accurate details due to language barrier, cognitive impairment, alcohol, or drug intoxication. |
Country | Name | City | State |
---|---|---|---|
Canada | Ottawa Hospital Research Institute | Ottawa | Ontario |
Lead Sponsor | Collaborator |
---|---|
Venkatesh Thiruganasambandamoorthy |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | A serious adverse event (SAE) occurring within 30 days of the 911 call | The definition of SAE is consistent with our previous syncope research studies including the CPSRS derivation and comprises of any one of the following: a) Death due to a cause of syncope or an unknown cause; b) Arrhythmia; c) Myocardial infarction; d) Identification of serious structural heart disease; e) Aortic dissection; f) Pulmonary embolism; g) Severe pulmonary artery hypertension; h) Subarachnoid hemorrhage; i) Significant hemorrhage; j) Other serious conditions such as ectopic pregnancy, pneumothorax, or sepsis that will require treatment, or any intervention used to treat a cause of syncope. | 30 days after the 911 call |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06038708 -
Head-up Tilt Test in Patients With Reflex Syncope and Asystolic Response Who Received a Dual-chamber Pacemaker With the Closed Loop Stimulation (CLS) and Participated in the BIOSync Trial
|
||
Completed |
NCT00069693 -
Evaluation of Chronic Orthostatic Intolerance
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Completed |
NCT02565238 -
BIO.MASTER.BioMonitor 2 Study
|
N/A | |
Active, not recruiting |
NCT01965899 -
Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor System
|
N/A | |
Completed |
NCT00746564 -
Study of New Implantable Loop Recorder
|
N/A | |
Completed |
NCT00359203 -
ISSUE3: International Study on Syncope of Uncertain Etiology 3
|
Phase 4 | |
Recruiting |
NCT04972071 -
SW-RCT Implementation of Canadian Syncope Risk Score Based Practice Recommendations
|
N/A | |
Completed |
NCT04198220 -
BIO|STREAM.ICM Obesity
|
||
Recruiting |
NCT04533425 -
Practical Approaches to Care in Emergency Syncope
|
||
Completed |
NCT05571254 -
The Management of Transient Loss of Consciousness and Suspected Syncope in European Emergency Departments
|
||
Recruiting |
NCT05621460 -
The Effect of Water Carbonation on Orthostatic Tolerance
|
N/A | |
Not yet recruiting |
NCT05957315 -
Mobile Cardiac Outpatient Telemetry for Unexplained Syncope
|
N/A | |
Recruiting |
NCT04615065 -
Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
|
||
Completed |
NCT05729724 -
Effect of Pharmacological Interventions on Systolic Blood Pressure Drops (SynABPM 2 Proof-of-concept)
|
||
Completed |
NCT05782712 -
Rapid Measurement of Adenosine in Syncope Patients
|
||
Completed |
NCT03786640 -
Abbott Brady 3T MRI PMCF
|
||
Recruiting |
NCT03803969 -
ConfirmRxTM: Posture and Activity
|
N/A | |
Recruiting |
NCT05575934 -
Management of Transitory Loss of Consciousness and Syncopes in the Emergency Department
|
||
Recruiting |
NCT04075084 -
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
|